Comments
Loading...

Cosciens Biopharma

CSCINASDAQ
Logo brought to you by Benzinga Data
$2.50
-0.29-10.55%
At close: -
$2.60
0.104.00%
After Hours: Dec 20, 4:00 PM EDT

Cosciens Biopharma (NASDAQ:CSCI) Stock, Earnings Estimates, EPS, And Revenue

Cosciens Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 12
EPS
$-1.850
Quarterly Revenue
$1.9M
Annual Revenue
(as of Sep 30)
$7.6M

Analyze the earnings history of Cosciens Biopharma using advanced sorting and filters.

Data brought to you by Benzinga APIs

Cosciens Biopharma (CSCI) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Mar 20242024-05-14$-4.74$-3.24-46.3 %
Dec 20232024-03-27$-4.64$-3.88-19.6 %
Sep 20232023-11-09$-3.40$-2.44-39.3 %
Jun 20232023-08-09$-2.08$-3.4840.2 %

Cosciens Biopharma (CSCI) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Jun 20242024-08-13$2.30M$1.10M109.1 %
Mar 20242024-05-14$4.00K$1.10M-99.6 %
Sep 20232023-11-09$3.00K$2.30M-99.9 %
Jun 20232023-08-09$2.25M$1.14M97.0 %

FAQ

Q

When is Cosciens Biopharma (NASDAQ:CSCI) reporting earnings?

A

Cosciens Biopharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Cosciens Biopharma (NASDAQ:CSCI)?

A

Cosciens Biopharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3 and the Actual EPS was $-1.85, which missed the estimate of $0.00.

Q

What were Cosciens Biopharma’s (NASDAQ:CSCI) revenues?

A

Cosciens Biopharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.

Browse earnings estimates, EPS, and revenue on all stocks.